Browsing by Author Deo, Shivashni Swasthika

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2015Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantationBlyth, Emily; Brown, Rebecca; Burgess, Jane; Clancy, Leighton; Deo, Shivashni Swasthika; Gottlieb, David; Ma, Chun; Micklethwaite, Kenneth; Simms, Renee; Western Clinical School: Westmead Institute for Medical Res; School of Public Health: Public Health; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical ResAddition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation, Cytotherapy, vol.17, 10, 2015,pp 1406-1420
2015Adoptive T-cell therapy for fungal infections in haematology patientsDeo, Shivashni Swasthika; Gottlieb, David; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResAdoptive T-cell therapy for fungal infections in haematology patients, Clinical & Translational Immunology, vol.4, 8, 2015,pp 1-7
2010The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological MalignanciesBendall, Linda; Deo, Shivashni Swasthika; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteThe Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies, Current Drug Targets, vol.11, 7, 2010,pp 823-833
2016Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cellsChen, Sharon; Deo, Shivashni Swasthika; Gottlieb, David; Meyer, Wieland; Sorrell, Tania; Clancy, Leighton; Halliday, Catriona; Virassamy, Balaji; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResStimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells, Cytotherapy, vol.18, 1, 2016,pp 65-79